Kate Dugan, VP Clinical Operations and Strategic Data Strategy will present with John “JJ” Spegele at the 9th annual SCOPE conference. Their presentation entitled, “Real world innovation & application in pipeline data approaches” will be given on February 15th.
The SCOPE (Summit for Clinical Ops Executives) offers three stimulating days of in-depth discussions in 18 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions focused on advances and innovative solutions in all aspects of clinical trial planning, management and operations: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy & Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Supply Chain, and Precision Medicine.
Global Specimen Solutions (GSS) was chosen to receive the 2017 Life Science Award for being a ground breaking organization in the Life Science Industry. Global Specimen Solutions provides innovative pipeline data management, analytics solutions, and services designed to optimize human specimen research. GSS will be presented with the award at a banquet on May 5th in Cary, NC.
View Full Article Here
Our Global Specimen Solutions team members of Amelia Wall Warner, Melissa Rawley-Payne and L. Scott Clark are excited to meet you at ISBER in Toronto from May 9-12th.
ISBER is a global biobanking organization which creates opportunities for networking, education, and innovations and harmonizes approaches to evolving challenges in biological and environmental repositories.
Continue reading Global Specimen Solutions Presents at ISBER
WBENC’s Summit engages participants to focus on the future of various industries, business networking, and development opportunities for women. The program highlights the 2016 America’s Top Corporations for Women Business Enterprises. The Summit occurs on March 21 – 23, 2017 in New Orleans, LA. The Women’s Business Enterprise National Council (WBENC), founded in 1997, is the largest third-party certifier of businesses owned, controlled, and operated by women in the United States. WBENC, a national 501(c)(3) non-profit, partners with 14 Regional Partner Organizations to provide its world class standard of certification to women-owned businesses throughout the country.
March 20-21, 2017 | Sheraton Philadelphia Downtown Hotel | Philadelphia, PA
The rapid evolution of central lab capabilities has been catalyzed by the expansion and sophistication of diagnostic testing availability. Never before has it been more important to streamline diagnostic solutions to increase patient recruitment, develop personalized medicine, cross-validate test results, and ultimately optimize clinical trials. The 3rd Central Labs & Diagnostics Partnerships Forum addresses the challenges to streamlining clinical trial processes with innovative solutions, so you can maintain constant focus on deliverables.
This forum is the only educational conference designed to guide you to implement and execute central lab strategic partnerships; desegregate sponsor-site-lab activity; and assess central lab competency through its diagnostics array, precision medicine, cross-protocol analytics, and more!
AGENDA DAY ONE Monday, March 20, 2017
Solve Key Clinical Trial Challenges by Turning Specimen Data into Actionable Insights: Break the Data Silo Barrier with New Tools for Real-Time Data Analysis
- Integrate vendor and in-house data streams to enable new, actionable insights and a forward-oriented strategy
- Examine new solutions from Global Specimen Solutions and Covance that provide innovative approaches for specimen tracking and chain of custody throughout the specimen life cycle
- Learn about how unified views of specimen data and near-real-time analytics allow in-life interventions for advanced clinical trial execution.
- Respond quickly to regulatory challenges or adverse events through an ability to analyze data across your pipeline and query samples with codified informed consent at your fingertips
- Maximize the value of your specimens and enable access to live data and analytics.
John Spegele, Vice President of Central Laboratory Services, Business Solutions and Enterprise Program Management Office, COVANCE
Amelia Wall Warner, Pharm.D., R.Ph., CEO and Founder, GLOBAL SPECIMEN SOLUTIONS, INC.
GSS will be attending Advanced Analytics for Clinical Data 2017 February 1 – 2 in San Francisco, CA. The Advanced Analytics for Clinical Data meeting provides an opportunity to meet with peers from across the industry who are successfully implementing advanced analytics to accelerate clinical R&D.
Visit the Advanced Analytics for Clinical Data website to learn more about the event.
Triangle Biotech Research Symposium V
October 11, 2016
North Carolina Biotechnology Center, Research Triangle Park
The BioPharma Research Council (BRC) brings together scientists across the many silos of biomedical research. This year the Triangle Biotech Research symposia of BRC will focus on D3D: Data, Drugs, Diagnostics. D3D aims to provide a platform for exploring the remarkable opportunities impacted by new perspectives on data generation and analysis.
CEO of Global Specimen Solutions, Inc., Amelia Warner, will be presenting at this conference.
Click Here to Learn More
October 6 – 7, 2016
Partnership in Clinical Trials focuses on clinical trials outsourcing, procurement, operations, and innovation as well as the disruptive technologies that will make your trials faster, better, and more cost-effective. Come see GSS’ COO/CFO Tom Wollman present ‘The Impact of In-Life Actionable Data on Clinical Trials Execution’ on October 6 as well as chair that afternoon’s session.
Biorepositories and Sample Management focuses on specimen management, informed consent precision medicine, next generation sequencing, and the final common rule. Come see Amelia Warner chair the morning sessions on Oct 6 and 7 and listen to her presentation on entitled ‘Making biobank data e-Valuable’ at 11am.
Click Here to Learn More
CEO of GSS, Amelia Warner, participated in the first Kayo Women in Healthcare Investing Conference in Durham Tuesday night. GSS was one of seven women-led startups in NC highlighted at the conference. The startups were highlighted because they are led by women and have worked to make key innovations in healthcare. Amelia was thrilled to be a part of the event.
Click Here to Learn More About the Conference
December 8 – 9, 2015
Clinical lab testing is becoming more complex. It is getting harder to implement new complex clinical protocols, especially ones requiring complicated bioassays for biologics. Additionally, an increase in rural global sites has added new hurdles for lab teams to overcome. Central lab outsourcing professionals must understand how the science and business of labs testing come together to clear the bottlenecks and keep trials on time and on budget. This is the only event dedicated to uncovering the secrets to effective central lab outsourcing and operations.
Learn More About the Event by Clicking Here or View the 2 Day Agenda
Continue reading 2nd Central Labs Partnership Forum